Literature DB >> 12700510

[Irritable bowel syndrome and healthcare consumption. An observational study in private gastroenterology].

Michel Dapoigny1, François Dyard, Jean-Charles Grimaud, Philippe Guyot, Eric van Ganse.   

Abstract

AIM: Little data is available on the management of irritable bowel syndrome (IBS) in daily practice. The purpose of our study was to study the relationship between the severity of IBS and healthcare consumption.
METHODS: During a cross-sectional epidemiological study undertaken by 330 private gastro-enterologists, the severity of IBS symptoms experienced by patients was quantified with Francis' score (limits 0-500) to study the relationship with the healthcare consumption.
RESULTS: Data obtained from 1407 patients (mean age: 52.3 +/- 15 years, females: 68%) were analysed. Symptoms were usually long-lasting (mean duration: 134.1 +/- 128.4 months); they had required on average 5.7 +/- 4.5 medical visits in the past year including 2.3 +/- 2.1 visits to a gastroenterologist. The mean number of additional investigations performed by patient was 1.3 +/- 1.4. Ninety one percent of them took at least one medication. The mean severity score was 268.5 +/- 85.2. Patients' distribution according to severity showed that 47.3% of the patients had symptoms of moderate severity and 44.9% of high severity. There was a significant relationship between, in one hand, severity of symptoms and, in the other hand, the number of visits (P<0.001), the number of additional investigations (P<0.001) and the number of prescribed medications (P<0.001).
CONCLUSION: There was a positive relationship between the severity of symptoms and the healthcare consumption in private gastroenterological practice. The data confirm the significant burden of IBS in France.

Entities:  

Mesh:

Year:  2003        PMID: 12700510

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

1.  Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.

Authors:  Mimi C Tan; Hashem B El-Serag; Jason K Hou
Journal:  Dig Dis Sci       Date:  2016-12-23       Impact factor: 3.199

2.  Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.

Authors:  Michel Dapoigny; Thierry Piche; Philippe Ducrotte; Bernard Lunaud; Jean-Michel Cardot; Annick Bernalier-Donadille
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

3.  On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.

Authors:  P Ducrotte; J C Grimaud; M Dapoigny; S Personnic; V O'Mahony; M C Andro-Delestrain
Journal:  Int J Clin Pract       Date:  2013-10-21       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.